Background: Cervical cancer is a preventable malignancy, given the availability of
primary and secondary prevention, via human papillomavirus (HPV) vaccination or screening,
respectively. Despite this fact, racial disparities HPV vaccination and screening still exist.
Objective: To review the data on primary and secondary prevention strategies for cervical cancer,
HPV vaccination and screening, respectively and their projected impact on both cervical cancer
rates and in reducing the disparity gap.
Method: Literature review.
Results: A disproportionate number of underserved minority women are not vaccinated and
Conclusion: Cervical cancer is a preventable disease. In the US, the burden is largely shouldered by
underserved women with limited or no access to primary and secondary prevention. Although it is
not possible at this time to measure the impact of vaccination and continued screening on this
disparity, it remains clear that this inequity will not be mitigated unless; access, coverage and
participation in HPV vaccination and cervical cancer screening programs improve for these women.